Publication:
Changes in the glycaemia risk index and its association with other continuous glucose monitoring metrics after initiation of an automated insulin delivery system in adults with Type 1 Diabetes

dc.contributor.coauthorShah, Viral N.
dc.contributor.coauthorKlonoff, David
dc.contributor.coauthorAkturk, Halis K.
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorKarakuş, Kağan Ege
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2025-01-19T10:32:18Z
dc.date.issued2023
dc.description.abstractAim: To evaluate the glycaemia risk index (GRI) and its association with other continuous glucose monitoring (CGM) metrics after initiation of an automated insulin delivery (AID) system in patients with type 1 diabetes (T1D). Materials and Methods: Up to 90 days of CGM data before and after initiation of an AID system from 185 CGM users with T1D were collected. GRI and other CGM metrics were calculated using cgmanalysis R software and were analysed for 24 hours, for both night-time and daytime. GRI values were assigned to five GRI zones: zone A (0-20), B (21-40), C (41-60), D (61-80) and E (81-100). Results: Compared with baseline, GRI and its components decreased significantly after AID initiation ( GRI: 48.7 +/- 21.8 vs. 29 +/- 13; hypoglycaemia component: 2.7 +/- 2.8 vs. 1.6 +/- 1.7; hyperglycaemia component: 25.3 +/- 14.5 vs. 15 +/- 8.5; P <.001 for all). The GRI was inversely correlated with time in range before (r = similar to 0.962) and after (r = similar to 0.961) AID initiation (P <.001 for both). GRI was correlated with time above range (before: r = 0.906; after = 0.910; P <.001 for both), but not with time below range (P >.05). All CGM metrics improved after AID initiation during 24 hours, for both daytime and night-time (P <.001 for all). Metrics improved significantly more during night-time than daytime (P <.01). Conclusions: GRI was highly correlated with various CGM metrics above, but not below target range, both before and after AID initiation.
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue11
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume25
dc.identifier.doi10.1111/dom.15208
dc.identifier.eissn1463-1326
dc.identifier.issn1462-8902
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85164560474
dc.identifier.urihttps://doi.org/10.1111/dom.15208
dc.identifier.urihttps://hdl.handle.net/20.500.14288/26367
dc.identifier.wos1026051600001
dc.keywordsContinuous glucose monitoring
dc.keywordsCSII
dc.keywordsInsulin pump
dc.keywordsTherapy
dc.keywordsType 1 Diabetes
dc.language.isoeng
dc.publisherWiley
dc.relation.ispartofDiabetes Obesity and Metabolism
dc.subjectMedicine
dc.titleChanges in the glycaemia risk index and its association with other continuous glucose monitoring metrics after initiation of an automated insulin delivery system in adults with Type 1 Diabetes
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorKarakuş, Kağan Ege
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files